Free Trial

IXICO (IXI) Competitors

IXICO logo
GBX 12.48 +0.48 (+4.00%)
As of 01/21/2025 05:12 AM Eastern

IXI vs. AOR, OPTI, IMM, RLM, NSCI, ONC, FAB, CIZ, BVX, and APTA

Should you be buying IXICO stock or one of its competitors? The main competitors of IXICO include AorTech International (AOR), OptiBiotix Health (OPTI), ImmuPharma (IMM), Realm Therapeutics (RLM), NetScientific (NSCI), Oncimmune (ONC), Fusion Antibodies (FAB), Cizzle Biotechnology (CIZ), BiVictriX Therapeutics (BVX), and Aptamer Group (APTA). These companies are all part of the "biotechnology" industry.

IXICO vs.

IXICO (LON:IXI) and AorTech International (LON:AOR) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, dividends, community ranking, profitability, media sentiment, risk and valuation.

AorTech International has lower revenue, but higher earnings than IXICO. IXICO is trading at a lower price-to-earnings ratio than AorTech International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IXICO£6M1.01-£1.87M-£0.04-312.00
AorTech International£539K0.00N/A-£3.70N/A

AorTech International has a net margin of 0.00% compared to IXICO's net margin of -31.10%. AorTech International's return on equity of 0.00% beat IXICO's return on equity.

Company Net Margins Return on Equity Return on Assets
IXICO-31.10% -16.99% -10.40%
AorTech International N/A N/A N/A

IXICO received 67 more outperform votes than AorTech International when rated by MarketBeat users. Likewise, 71.64% of users gave IXICO an outperform vote while only 67.54% of users gave AorTech International an outperform vote.

CompanyUnderperformOutperform
IXICOOutperform Votes
144
71.64%
Underperform Votes
57
28.36%
AorTech InternationalOutperform Votes
77
67.54%
Underperform Votes
37
32.46%

In the previous week, IXICO's average media sentiment score of 0.00 equaled AorTech International'saverage media sentiment score.

Company Overall Sentiment
IXICO Neutral
AorTech International Neutral

56.0% of IXICO shares are held by institutional investors. 30.3% of IXICO shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

IXICO beats AorTech International on 6 of the 10 factors compared between the two stocks.

Get IXICO News Delivered to You Automatically

Sign up to receive the latest news and ratings for IXI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IXI vs. The Competition

MetricIXICOBiotechnology IndustryMedical SectorLON Exchange
Market Cap£6.03M£177.42M£5.39B£2.04B
Dividend Yield1.27%3.64%5.37%5.16%
P/E Ratio-312.00131.1588.831,926.65
Price / Sales1.0119,225.091,284.87384,006.48
Price / Cash2.2513.0136.6029.21
Price / Book0.599.234.963.08
Net Income-£1.87M-£20.89M£117.89M£183.60M
7 Day Performance13.35%0.40%2.75%3.09%
1 Month Performance6.99%2.27%3.63%3.42%
1 Year Performance-2.12%131.63%27.26%165.41%

IXICO Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IXI
IXICO
N/AGBX 12.48
+4.0%
N/A-2.1%£6.03M£6M-312.0089Gap Up
AOR
AorTech International
N/AN/AN/AN/A£19.99M£539,000.00-33.383
OPTI
OptiBiotix Health
N/AGBX 18
+2.9%
N/A-31.2%£17.63M£1.26M-600.001Gap Up
IMM
ImmuPharma
N/AGBX 3.37
-10.1%
N/A+73.9%£14.01M£94,819.00-336.5013Gap Down
RLM
Realm Therapeutics
N/AN/AN/AN/A£13.41M£501,919.00-0.66N/A
NSCI
NetScientific
N/AN/AN/AN/A£12.81M£1.45M-486.3626
ONC
Oncimmune
N/AGBX 13
flat
N/A-53.9%£9.64M£1.21M-433.3352
FAB
Fusion Antibodies
N/AGBX 9.30
+0.5%
N/A+29.0%£8.87M£1.14M-232.5048Gap Up
CIZ
Cizzle Biotechnology
N/AGBX 2.17
+14.2%
N/A-19.2%£8.60M£25,000.00-217.004
BVX
BiVictriX Therapeutics
N/AN/AN/AN/A£8.25MN/A-250.0017Gap Up
High Trading Volume
APTA
Aptamer Group
N/AGBX 0.38
+11.8%
N/A-64.7%£7.30M£1.03M-4.7537Gap Up

Related Companies and Tools


This page (LON:IXI) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners